Cresco Labs (CRLBF) files Form 6-K on senior secured term loan and news release

Q: What key agreements are referenced for Cresco Labs Inc. (CRLBF)?

The filing references a Senior Secured Term Loan Agreement dated August 13, 2025. This agreement is listed as Exhibit 99.1, indicating a secured lending arrangement documented alongside other information in the furnished materials.

Q: Who signed the Cresco Labs Inc. (CRLBF) September 2025 Form 6-K?

The Form 6-K was signed on behalf of Cresco Labs Inc. by Charles Bachtell , the company’s Chief Executive Officer, on September 22, 2025, confirming the company’s authorization of the submitted information.

Q: What is Cresco Labs Inc. (CRLBF)’s status as a foreign private issuer?

Cresco Labs Inc. files as a foreign private issuer and uses Form 20-F for annual reports. The Form 6-K serves as a current report mechanism to furnish interim information such as financing agreements and related news releases.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

6-K

Rhea-AI Filing Summary

Cresco Labs Inc. filed a Form 6-K as a foreign private issuer for September 2025. The filing notes that the company entered into a Senior Secured Term Loan Agreement dated August 13, 2025 and issued a related news release on the same date.

Form 6-K: How Foreign Companies Report to the SEC →

09/22/2025 - 12:46 PM

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 6-K

Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16

Under the Securities Exchange Act of 1934

For the month of September, 2025

000-56241

(Commission File Number)

Cresco Labs Inc.
(Exact name of Registrant as specified in its charter)

600 W. Fulton Street, Suite 800
Chicago, IL 60661
(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☐ Form 40-F ☒


EXHIBIT INDEX

Exhibit No.						Description
99.1						Senior Secured Term Loan Agreement dated August 13, 2025
99.2						News Release dated August 13, 2025

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

CRESCO LABS INC.

Date: September 22, 2025

By:

/s/ Charles Bachtell

Charles Bachtell

Chief Executive Officer

Source: View Original Filing on SEC EDGAR

FAQ

What does Cresco Labs Inc. (CRLBF) report in this Form 6-K?

Cresco Labs Inc. reports that it has furnished a Form 6-K for September 2025, highlighting a Senior Secured Term Loan Agreement dated August 13, 2025 and a related news release issued the same day.

What key agreements are referenced for Cresco Labs Inc. (CRLBF)?

The filing references a Senior Secured Term Loan Agreement dated August 13, 2025. This agreement is listed as Exhibit 99.1, indicating a secured lending arrangement documented alongside other information in the furnished materials.

What exhibits are attached to the Cresco Labs (CRLBF) September 2025 Form 6-K?

The exhibit index lists two items: Exhibit 99.1 is a Senior Secured Term Loan Agreement dated August 13, 2025, and Exhibit 99.2 is a news release dated August 13, 2025 relating to that financing development.

Who signed the Cresco Labs Inc. (CRLBF) September 2025 Form 6-K?

The Form 6-K was signed on behalf of Cresco Labs Inc. by Charles Bachtell, the company’s Chief Executive Officer, on September 22, 2025, confirming the company’s authorization of the submitted information.

What is Cresco Labs Inc. (CRLBF)’s status as a foreign private issuer?

Cresco Labs Inc. files as a foreign private issuer and uses Form 20-F for annual reports. The Form 6-K serves as a current report mechanism to furnish interim information such as financing agreements and related news releases.